Filing Details
CHINA PHARMA HOLDINGS, INC. (AMEX:CPHI) filed a Form 8-K with the Securities and Exchange Commission on July 22, 2026, disclosing a material event.
8k filedAMEX:CPHI
CHINA PHARMA HOLDINGS, INC. (CPHI) Reports Material Event to SEC
Filing Details CHINA PHARMA HOLDINGS, INC. (AMEX:CPHI) filed a Form 8-K with the Securities and Exchange Commission on July 22, 2026, disclosing a material event. Market Context…
Market Context
CHINA PHARMA HOLDINGS, INC.'s stock currently trades at $1.71 with a market capitalization of $4.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CHINA PHARMA HOLDINGS, INC.'s stock.
All SEC filings for CHINA PHARMA HOLDINGS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CPHI Stock Page
Frequently Asked Questions
Where can I read CPHI's SEC filings?
Browse all filings on our CPHI SEC filings page.
What types of SEC filings does CHINA PHARMA HOLDINGS, INC. file?
Public companies like CHINA PHARMA HOLDINGS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.